MRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration

Peptides

Volumn 31, Issue 12, 2010, Pages 2200-2208

  Cespedes, Isabel C ^a,b   De Oliveira, Amanda R ^b   Da Silva, Joelcimar M ^b   Da Silva, André V ^b   Sita, Luciane V ^b   Bittencourt, Jackson C ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Benzodiazepines; CRF receptors; Edinger Westphal nucleus; Paraventricular nucleus of the hypothalamus; Stress; Urocortins

Indexed keywords

ALPRAZOLAM; CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; PROTEIN FOS; UROCORTIN I;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; EDINGER WESTPHAL NUCLEUS; FOOTSHOCK; HYPOTHALAMUS; IMMOBILIZATION STRESS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS MIDLINE NUCLEUS;

ALPRAZOLAM; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PHYSIOLOGICAL; UROCORTINS;

ANIMALIA;

EID: 78049470909     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.08.022     Document Type: Article

References (67)

1. S.L. Alexander, C.H. Irvine, J.H. Livesey, and R.A. Donald Effect of isolation stress on concentrations of arginine vasopressin, alpha-melanocyte- stimulating hormone and ACTH in the pituitary venous effluent of the normal horse J Endocrinol 116 1988 325 334
2. H. Ashton Guidelines for the rational use of benzodiazepines. When and what to use Drugs 48 1994 25 40
3. H.A. Baldwin, S. Rassnick, J. Rivier, G.F. Koob, and K.T. Britton CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat Psychopharmacology (Berl) 103 1991 227 232
4. R.D. Barenbaum, and L. Rilla Manta New molecular targets in pharmacological treatment of anxiety disorders Vertex 15 Suppl. 1 2004 5 11
5. H.S. Beyer, S.G. Matta, and B.M. Sharp Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat Endocrinology 123 1988 2117 2123
6. E.B. Binder, and C.B. Nemeroff The CRF system, stress, depression and anxiety-insights from human genetic studies Mol Psychiatry 15 2009 574 588
7. J.C. Bittencourt, and P.E. Sawchenko Do centrally administered neuropeptides access cognate receptors? An analysis in the central corticotropin-releasing factor system J Neurosci 20 2000 1142 1156
8. K.T. Britton, J. Morgan, J. Rivier, W. Vale, and G.F. Koob Chlordiazepoxide attenuates response suppression induced by corticotropin- releasing factor in the conflict test Psychopharmacology (Berl) 86 1985 170 174
9. E. Bullitt Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat J Comp Neurol 296 1990 517 530
10. S. Ceccatelli, M.J. Villar, M. Goldstein, and T. Hokfelt Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress Proc Natl Acad Sci U S A 86 1989 9569 9573
11. D.T. Chalmers, T.W. Lovenberg, and E.B. De Souza Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression J Neurosci 15 1995 6340 6350
12. A. Chen, M. Perrin, B. Brar, C. Li, P. Jamieson, and M. Digruccio Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids Mol Endocrinol 19 2005 441 458
13. R.L. Cole, and P.E. Sawchenko Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus J Neurosci 22 2002 959 969
14. D.S. Cowley, P.P. Roy-Byrne, A. Radant, J.C. Ritchie, D.J. Greenblatt, and C.B. Nemeroff Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment Neuropsychopharmacology 12 1995 147 157
15. F.M. Dautzenberg, and R.L. Hauger The CRF peptide family and their receptors: yet more partners discovered Trends Pharmacol Sci 23 2002 71 77
16. M.E. Davis, C.J. Pemberton, T.G. Yandle, J.G. Lainchbury, M.T. Rademaker, and M.G. Nicholls Urocortin-1 infusion in normal humans J Clin Endocrinol Metab 89 2004 1402 1409
17. E.R. de Kloet Hormones, brain and stress Endocr Regul 37 2003 51 68
18. A.J. Dunn, and S.E. File Corticotropin-releasing factor has an anxiogenic action in the social interaction test Horm Behav 21 1987 193 202
19. A.J. Dunn, and A.H. Swiergiel Effects of acute and chronic stressors and CRF in rat and mouse tests for depression Ann N Y Acad Sci 1148 2008 118 126
20. B. Gaszner, V. Csernus, and T. Kozicz Urocortinergic neurons respond in a differentiated manner to various acute stressors in the Edinger-Westphal nucleus in the rat J Comp Neurol 480 2004 170 179
21. M. Heilig, and G.F. Koob A key role for corticotropin-releasing factor in alcohol dependence Trends Neurosci 30 2007 399 406
22. J.P. Herman, and W.E. Cullinan Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis Trends Neurosci 20 1997 78 84
23. J.P. Herman, N.K. Mueller, and H. Figueiredo Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration Ann N Y Acad Sci 1018 2004 35 45
24. J.B. Hogan, D.B. Hodges Jr., S. Lelas, P.J. Gilligan, J.F. McElroy, and M.D. Lindner Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests Psychopharmacology (Berl) 178 2005 410 419
25. F. Holsboer The corticosteroid receptor hypothesis of depression Neuropsychopharmacology 23 2000 477 501
26. S.M. Hsu, and L. Raine Protein A, avidin, and biotin in immunohistochemistry J Histochem Cytochem 29 1981 1349 1353
27. T. Imaki, J.L. Nahon, C. Rivier, P.E. Sawchenko, and W. Vale Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress J Neurosci 11 1991 585 599
28. T. Imaki, T. Shibasaki, M. Hotta, and H. Demura Early induction of c-fos precedes increased expression of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus after immobilization stress Endocrinology 131 1992 240 246
29. T. Imaki, and W. Vale Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus Brain Res 623 1993 223 228
30. T. Imaki, X.Q. Wang, T. Shibasaki, S. Harada, N. Chikada, and C. Takahashi Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF) gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN) Brain Res Mol Brain Res 32 1995 261 270
31. K.T. Kalogeras, A.E. Calogero, T. Kuribayiashi, I. Khan, W.T. Gallucci, and M.A. Kling In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications J Clin Endocrinol Metab 70 1990 1462 1471
32. T. Kishimoto, R.V. Pearse 2nd, C.R. Lin, and M.G. Rosenfeld A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle Proc Natl Acad Sci U S A 92 1995 1108 1112
33. G.F. Koob, and M. Le Moal Review. Neurobiological mechanisms for opponent motivational processes in addiction Philos Trans R Soc Lond B: Biol Sci 363 2008 3113 3123
34. G.F. Koob, and E.P. Zorrilla Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor Curr Opin Investig Drugs 11 2010 63 71
35. W.A. Kostich, A. Chen, K. Sperle, and B.L. Largent Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor Mol Endocrinol 12 1998 1077 1085
36. T. Kozicz On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation Gen Comp Endocrinol 153 2007 235 240
37. T. Kozicz, D. Tilburg-Ouwens, G. Faludi, M. Palkovits, and E. Roubos Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression Neuroscience 152 2008 1015 1023
38. R. Krulik, and M. Cerny Effect of chlordiazepoxide on stress in rats Life Sci I 10 1971 145 151
39. H.Y. Li, A. Ericsson, and P.E. Sawchenko Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms Proc Natl Acad Sci U S A 93 1996 2359 2364
40. H.Y. Li, and P.E. Sawchenko Hypothalamic effector neurons and extended circuitries activated in "neurogenic" stress: a comparison of footshock effects exerted acutely, chronically, and in animals with controlled glucocorticoid levels J Comp Neurol 393 1998 244 266
41. T.W. Lovenberg, C.W. Liaw, D.E. Grigoriadis, W. Clevenger, D.T. Chalmers, and E.B. De Souza Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain Proc Natl Acad Sci U S A 92 1995 836 840
42. J.F. McElroy, K.A. Ward, K.L. Zeller, K.W. Jones, P.J. Gilligan, and L. He The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats Psychopharmacology (Berl) 165 2002 86 92
43. E. Merlo Pich, M. Lorang, M. Yeganeh, F. Rodriguez de Fonseca, J. Raber, and G.F. Koob Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis J Neurosci 15 1995 5439 5447
44. S. Michelini, G.B. Cassano, F. Frare, and G. Perugi Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders Pharmacopsychiatry 29 1996 127 134
45. National Research Council of the National Academy of Sciences Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research 7th ed. 2003 The National Academies Press Washington
46. T.C. Neylan Hans Selye and the field of stress research J Neuropsych Clin N 10 1998 230 231
47. Z. Nie, E.P. Zorrilla, S.G. Madamba, K.C. Rice, M. Roberto, and G.R. Siggins Presynaptic CRF1 receptors mediate the ethanol enhancement of GABAergic transmission in the mouse central amygdala ScientificWorldJournal 9 2009 68 85
48. M.J. Owens, G. Bissette, and C.B. Nemeroff Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain Synapse 4 1989 196 202
49. W. Pan, and A.J. Kastin Urocortin and the brain Prog Neurobiol 84 2008 148 156
50. M. Perrin, C. Donaldson, R. Chen, A. Blount, T. Berggren, and L. Bilezikjian Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart Proc Natl Acad Sci U S A 92 1995 2969 2973
51. S. Rassnick, S.C. Heinrichs, K.T. Britton, and G.F. Koob Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal Brain Res 605 1993 25 32
52. T. Rohrer, V. von Richthofen, C. Schulz, J. Beyer, and H. Lehnert The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam Horm Metab Res 26 1994 200 206
53. A.E. Ryabinin, and A.Z. Weitemier The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption Brain Res Rev 52 2006 368 380
54. Z. Sarnyai, E. Biro, J. Gardi, M. Vecsernyes, J. Julesz, and G. Telegdy Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats Brain Res 675 1995 89 97
55. P.E. Sawchenko, Z.F. Yuan, F. Laplante, R.A. Rissman, and J.C. Bittencourt Corticotropin-releasing Hormone: Integration of Adaptive responses to stress. Encyclopedia of Neuroscience 2009 Academic Press Oxford pp. 239-45
56. R. Sinha Chronic stress, drug use, and vulnerability to addiction Ann N Y Acad Sci 1141 2008 105 130
57. K.H. Skelton, C.B. Nemeroff, D.L. Knight, and M.J. Owens Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems J Neurosci 20 2000 1240 1248
58. K.H. Skelton, D. Oren, D.A. Gutman, K. Easterling, S.G. Holtzman, and C.B. Nemeroff The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal Eur J Pharmacol 571 2007 17 24
59. K.H. Skelton, M.J. Owens, and C.B. Nemeroff The neurobiology of urocortin Regul Pept 93 2000 85 92
60. D.F. Swaab, A.M. Bao, and P.J. Lucassen The stress system in the human brain in depression and neurodegeneration Ageing Res Rev 4 2005 141 194
61. N.R. Swerdlow, M.A. Geyer, W.W. Vale, and G.F. Koob Corticotropin- releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide Psychopharmacology (Berl) 88 1986 147 152
62. A.H. Swiergiel, Y. Li, Z.Y. Wei, and A.J. Dunn Effects of chlordiazepoxide on footshock- and corticotropin-releasing factor-induced increases in cortical and hypothalamic norepinephrine secretion in rats Neurochem Int 52 2008 1220 1225
63. A.V. Turnbull, J. Vaughan, J.E. Rivier, W.W. Vale, and C. Rivier Urocortin is not a significant regulator of intermittent electrofootshock- induced adrenocorticotropin secretion in the intact male rat Endocrinology 140 1999 71 78
64. Y.M. Ulrich-Lai, and J.P. Herman Neural regulation of endocrine and autonomic stress responses Nat Rev Neurosci 10 2009 397 409
65. W. Vale, J. Spiess, C. Rivier, and J. Rivier Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin Science 213 1981 1394 1397
66. J. Vaughan, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, and S. Sutton Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor Nature 378 1995 287 292
67. M.S. Weinberg, M. Girotti, and R.L. Spencer Restraint-induced fra-2 and c-fos expression in the rat forebrain: relationship to stress duration Neuroscience 150 2007 478 486